Tregaron Capital is pleased to announce that it has participated in the acquisition of TGaS Advisors in a transaction led by founder Stephen Gerard and members of the senior management team, together with a consortium of financial investors including Gemini Investors, Triangle Capital Corporation and Salem Investment Partners.
TGaS Advisors, based in East Norriton, PA, is the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies. The Company provides the only comprehensive series of benchmarking solutions and advisory services for objectively improving the strategy and effectiveness of pharmaceutical operations. Its client roster includes the top 10, and the majority of the top 50, global pharmaceutical companies. Learn more at www.TGaS.com.
About Tregaron Capital
Based in Palo Alto, CA, Tregaron invests in small to mid-sized companies with EBITDA between $1 and $5 million. The firm’s focus is on providing mezzanine debt and equity capital for growth and owner liquidity as well as strategic support to achieve the next level of success. Tregaron is designed to provide senior focus on each opportunity and portfolio company. Our principals bring a wealth of skills, experience, and energy to each situation, enabling fast and confident decision making and meaningful support in business-building. Find out more at www.TregaronCapital.com.